Updated guidance offers evidence-based strategies to optimize the diagnosis and treatment of non-metastatic upper tract ...

Bladder cancer may be scary but it will help to know that depending on the stage of cancer treatment will help control or ...

A new review was published in Volume 16 of Oncotarget on June 17, 2025, titled "Optimizing enfortumab vedotin plus ...

According to the latest study from BCC Research, "Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic ...

In An Exercise in Uncertainty, Jon Gluck traces decades of waiting, watching, enduring experimental treatment, and miraculously beating the odds.

Investigators used the Shiny method, which employs artificial intelligence, to indirectly compare the efficacy of novel systemic therapies for urothelial cancer using phase 3 trial data.

Aidixi plus toripalimab met progression-free and overall survival study end points versus chemo for patients with HER2-expressing urothelial carcinoma.

Urothelial carcinoma, or transitional cell carcinoma, is the most common bladder cancer and grows in the urothelial cells lining the urinary tract.

The National Comprehensive Cancer Network recommends that all patients with stage IVA and stage IVB urothelial carcinoma have molecular analysis that integrates at least FGFR3 testing to help ...

Medically reviewed by Steffini Stalos, DO Bladder cancer occurs when cancerous cells form in the tissues of the bladder, the hollow organ in your abdomen that stores urine. The bladder has several ...

Dr. Kobashi says that the most common symptom of bladder cancer is blood in urine. The blood can range from bright red to a rusty brown color and can make urine appear more brown than yellow. Or, it ...